Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures
By GlobeNewswire Published on May 19, 2025, 13:00 IST
May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real time
Catheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart disease
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe. Building on its success in the United States, VeriSight Pro brings real-time 3D imaging directly inside the heart, helping physicians perform procedures with greater clarity — without the need for general anesthesia.
Designed for procedures such as transcatheter valve repair and left atrial appendage closure, VeriSight Pro offers high-resolution 2D and 3D visualization directly within the heart chambers. This enables confident clinical decision-making in structural heart and electrophysiology interventions, while removing the need for general anesthesia and associated risks.
'With VeriSight Pro 3D ICE, we now have the ability to see detailed cardiac anatomy from inside the heart in real time,' said Prof. Dr. Jörg Hausleiter, Ludwig-Maximilians-Universität (LMU) Munich, Germany. 'This helps streamline our workflows and makes complex procedures more accessible to patients who may not tolerate more invasive imaging approaches.'
Addressing structural heart disease with less burden on patients and hospitals
Structural heart disease is a growing challenge across Europe, with increasing volumes of transcatheter valve repair and closure procedures. Today, many of these are supported by transesophageal echocardiography (TEE), which often requires general anesthesia, additional staff, and extended room time. In contrast, 3D ICE imaging provides detailed visualization from within the heart through a catheter introduced via the femoral vein, reducing the need for general anesthesia and recovery time in the Post-Anesthesia Care Unit (PACU), which can shorten hospital stays and lower costs.
VeriSight Pro is a pioneering innovation: a miniaturized ultrasound probe, approximately 3 millimeters in diameter, embedded at the tip of a thin, steerable catheter. This tiny device can be navigated through the vascular system and into the heart chambers, where it delivers high-quality 2D and 3D images in real time. Imaging the heart from within, with control over the scan angle, opens entirely new possibilities for guiding structural heart interventions. Physicians can assess anatomy, guide device placement, and confirm procedural results — all from a single access point, and without the need for more invasive imaging techniques.
As the first ICE catheter to miniaturize the same 3D imaging technology used in TEE, VeriSight Pro helps address key barriers in delivering efficient, scalable care — from patient tolerance to resource availability in interventional suites.
'VeriSight Pro reflects our ongoing commitment to delivering clinically relevant innovations that enhance precision, reduce procedure complexity, and improve the care experience,' said Stacy Beske, Business Leader of Image-Guided Therapy Devices at Philips. 'Its availability in Europe is an important milestone in helping more patients benefit from image-guided, minimally invasive heart procedures, while supporting care teams with integrated solutions that adapt to the way they work.'
Part of an integrated portfolio for structural heart care
VeriSight Pro is part of Philips' structural heart disease ecosystem, seamlessly integrating with Philips' EPIQ ultrasound systems, which in turn integrate with the Azurion image-guided therapy platform. Combined with tools such as EchoNavigator, Philips offers an end-to-end solution for clinicians performing procedures such as tricuspid and mitral valve repair and replacement, atrial septal defect closure, and left atrial appendage occlusion.
The catheter's unique features — including xPlane and iRotate technologies — allow physicians to visualize two imaging planes simultaneously and digitally adjust views without physically repositioning the catheter tip. These capabilities enable precise assessment and device deployment with fewer imaging steps.
Showcasing 3D ICE in action at EuroPCR 2025
Philips will highlight VeriSight Pro and its role in structural heart interventions at EuroPCR 2025 in Paris, May 20–23. Key activities include: Physician-led symposium : 'Advanced Imaging in Structural Heart Disease Interventions' (Tuesday, May 20), featuring case insights from U.S. and European clinicians using 3D ICE and AI-assisted imaging.
: (Tuesday, May 20), featuring case insights from U.S. and European clinicians using 3D ICE and AI-assisted imaging. Hands-on training village : Real-world imaging practice with VeriSight Pro on Mentice simulators, supported by Philips experts and in collaboration with Edwards Lifesciences.
: Real-world imaging practice with VeriSight Pro on Mentice simulators, supported by Philips experts and in collaboration with Edwards Lifesciences. Immersive VR-based launch training: Invite-only program showcasing clinical protocols for left atrial appendage occlusion and TV TEER, including headset-based live procedure simulations.
These sessions will offer clinicians an in-depth look at how 3D ICE is being applied in real-world structural heart procedures — from imaging protocols to workflow integration and clinical outcomes. A complete and detailed overview of sessions can be found here: www.philips.com/europcr.
For further information, please contact:
Joost MalthaPhilips Global External RelationsTel.: +31 6 10 55 8116
E-Mail: [email protected]
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachment Philips VeriSight Pro 3D ICE catheter
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Could BigBear.ai Stock Turn a $25,000 Investment Into $1 Million?
offers a wide range of artificial intelligence solutions. While it does possess some attractive potential, its business hasn't taken off -- at least, not yet. 10 stocks we like better than › Many investors see a lot of potential in (NYSE: BBAI). The data analytics company is sometimes compared to Palantir Technologies (NASDAQ: PLTR) in that it can serve many industries, has secured government contracts, and is utilizing artificial intelligence (AI) to expand upon its opportunities. But is that comparison really justified? Could -- with its small-cap size of just $1 billion or so today -- become the next hot growth stock? And if so, does it have the potential to turn a $25,000 investment into $1 million over the long term? For a $25,000 investment in to grow to $1 million or more, the stock would need to grow by 40 times. That would mean its market cap needs to reach more than $45 billion. To earn such a valuation, the company would need to show significant improvements on both its top and bottom lines. The good news is that many companies are spending heavily on AI in order to enhance their decision-making capabilities and improve overall efficiency. There are serious opportunities for to capitalize on those trends in the long run. The problem is that while offers various AI solutions (including predictive intelligence, cybersecurity, modeling, and digital identity management), that hasn't translated into significant revenue growth. The company's growth rate over the past few years has averaged just under 4%. This year, management is forecasting revenue between $160 million and $180 million. The low end of the forecast would be almost flat relative to the $158 million it achieved in 2024. If it hits the top end of the range, its revenue will grow by around 14%. While that's decent, it's not the type of AI-powered growth that investors may be expecting or that may be necessary for the stock to take off. has been securing defense-related contracts similar to those pursued by Palantir, which has been a key partner for governments around the world. Most recently, announced a collaboration with Hardy Dynamics, which provides the U.S. Army with "advanced AI capabilities." But while they may offer somewhat comparable services, that doesn't mean that these two businesses are the same. What has made Palantir a hot AI stock is the company's relentless growth. It has been expanding both its commercial and government businesses at impressive rates. During the first three months of 2025, Palantir's U.S. commercial revenue grew by 71% year over year, and its U.S. government revenue was up by 45%. meanwhile, may not even generate 10% growth across its entire business this year. Further, while Palantir is profitable, is nowhere near breaking even. It posted a net loss of $62 million in the first quarter -- more than the $35 million in revenue it brought in. Until can show that it can generate the type of impressive growth that Palantir has achieved, there's little reason to expect that it can become a top growth stock. While does possess potential, so do many of the numerous other companies that are also offering AI solutions. Ultimately, it's the results that matter. Given its low valuation, may seem like a stock worth taking a chance on. After all, if its growth rate does accelerate, the stock could soar. If it were to simply get back to its 52-week high of $10.36, it would more than double in value from where it is today. But at the same time, the stock could also end up plummeting back toward its 52-week low of just over $1.16 if it continues to underwhelm investors with its results. When it comes to such a volatile stock, it's hard to predict which direction it will go. So while may be an intriguing stock to watch, it's not going to be a suitable holding for most investors. And there's little reason at this stage to expect that it has the potential to be a millionaire-making investment. Before you buy stock in consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy. Could Stock Turn a $25,000 Investment Into $1 Million? was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
19 minutes ago
- Yahoo
Canada Glucose Monitoring Device Market Forecast & Opportunities, 2025-2030: Increasing Adoption of Advanced Glucose Monitoring Technologies
The Canada glucose monitoring device market is expanding due to rising diabetes cases and technological advancements. Key opportunities include increased demand for continuous and flash glucose monitors for proactive management. However, high costs limit access, especially for uninsured patients. Advanced CGMs and data-integrated solutions offer growth potential. Canadian Glucose Monitoring Device Market Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Canada Glucose Monitoring Device Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to offering. The Canada Glucose Monitoring Device Market was valued at USD 1.23 Billion in 2024 and is expected to reach USD 2.54 Billion by 2030, rising at a CAGR of 12.85% The market is witnessing significant expansion driven by rapid technological advancements and the rising prevalence of diabetes across the country. With diabetes recognized as a pressing public health concern, demand for efficient glucose monitoring tools has surged. According to Health Canada, the global diabetic population is expected to more than double by 2050, underscoring the urgent need for accessible monitoring solutions. As a major contributor to global morbidity and mortality, diabetes has propelled the adoption of devices like continuous and flash glucose monitors, which offer real-time data and enable proactive disease management. Rising Prevalence of Diabetes in Canada The growing number of diabetes cases across Canada is a critical factor driving the glucose monitoring device market. By 2020-2021, approximately 3.7 million Canadians, or 9.4% of the population aged one and above, were diagnosed with diabetes, a figure that climbs to 27% among those aged 65 and older. This demographic shift underscores the escalating need for effective blood sugar monitoring tools. Devices such as continuous glucose monitors (CGMs) and flash glucose monitors (FGMs) have become essential for real-time tracking and management of glucose levels. They support timely interventions and help mitigate complications like cardiovascular disease, kidney damage, and neuropathy, thereby improving patient outcomes and quality of life. High Cost of Advanced Monitoring Devices The cost of advanced glucose monitoring technologies remains a major hurdle to widespread use. While some government programs offer financial assistance, not all individuals qualify, and personal expenses can be steep. For instance, individuals with type 1 diabetes in Alberta may face up to $7,000 in annual out-of-pocket expenses, while those with type 2 diabetes could spend as much as $6,000. These costs include the initial device, sensors, and transmitters, which can be financially burdensome for patients lacking sufficient insurance coverage. This financial barrier often restricts access to newer technologies, affecting diabetes care and control among economically vulnerable populations. Adoption of Advanced Glucose Monitoring Technologies A prominent trend in the Canadian market is the increasing shift towards advanced glucose monitoring systems, particularly CGMs. These devices deliver continuous glucose readings, offering superior glycemic management and reducing complications such as hypo- and hyperglycemia. Compared to traditional finger-prick methods, CGMs enhance user convenience and improve quality of life. Integration with insulin pumps and mobile apps has enabled real-time data sharing and automated insulin delivery, allowing healthcare providers to personalize treatment plans more effectively. As awareness of these benefits grows, the uptake of advanced glucose monitoring technologies is expected to rise steadily across Canada. Key Attributes: Report Attribute Details No. of Pages 70 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $1.23 Billion Forecasted Market Value (USD) by 2030 $2.54 Billion Compound Annual Growth Rate 12.8% Regions Covered Canada Report Scope Key Market Players: Medtronic of Canada Ltd Abbott Canada. Johnson & Johnson Inc/Canada Braun of Canada F. Hoffmann-La Roche Limited. Ascensia Diabetes Care. Sanofi-Aventis Canada Inc. Eli Lilly Canada Inc. Canada Glucose Monitoring Device Market, By Product Type: Self-Blood Glucose Monitoring Devices Continuous Glucose Monitoring Devices Canada Glucose Monitoring Device Market, By Application: Type 1 Diabetes Type 2 Diabetes Gestational Diabetes Canada Glucose Monitoring Device Market, By End User: Home Care Settings Hospital Others Canada Glucose Monitoring Device Market, By Region: Ontario Quebec Alberta British Columbia Saskatchewan and Manitoba Rest of Canada For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Canadian Glucose Monitoring Device Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
24 minutes ago
- Yahoo
Functional Safety Market Size expected to reach US$ 13.00 billion by 2031, Experiences Growth Owing to Increased Automation Across Industries
The report, provides several stakeholders—including component providers, system technology integrators, system manufacturers and others—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. US & Canada, June 06, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the global Functional Safety market is observing significant growth owing to increased automation across industries and stricter regulatory requirements. The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the Functional Safety are applicable in a vast array of end user industries that are expected to register strength during the coming years. To explore the valuable insights in the Functional Safety Market report, you can easily download a sample PDF of the report – Overview of Report Findings Market Growth: The Functional Safety market is expected to reach US$ 13.00 billion by 2031 from US$ 7.63 billion in 2024, at a CAGR of 7.9% during the forecast period. The need for sophisticated safety systems to reduce risks is being driven by the increase in automation in sectors like manufacturing, automotive, and energy. Businesses are being compelled to invest in strong, practical safety solutions due to strict government laws and safety standards. The need for advanced safety measures is growing as a result of the deployment of Industry 4.0 technologies, such as artificial intelligence (AI) and the Internet of Things (IoT). Increased Automation Across Industries: As automation systems become more complex and interconnected, the potential for system failures and associated risks also increases. Industries such as manufacturing, oil and gas, and automotive require robust safety mechanisms to monitor and control these automated processes. Automated systems, while reducing human intervention, can still pose risks if not properly managed. Functional safety systems help mitigate these risks by ensuring machinery operates within safe limits and triggering protective actions when deviations occur. Governments and regulatory bodies impose strict safety requirements to protect workers, consumers, and the environment. Standards such as ISO 26262 for automotive systems and IEC 61508 for industrial applications mandate the integration of functional safety principles in system design. Compliance with these regulations reduces legal liabilities and improves product reliability. Integration of AI and Machine Learning: The incorporation of AI and machine learning in safety systems is a significant trend. These technologies enable real-time data analysis and predictive maintenance, enhancing fault detection accuracy and decision-making in complex environments like autonomous vehicles and smart factories. For example, AI-driven safety solutions can predict potential failures before they occur, allowing for proactive maintenance and reducing downtime. Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Asia Pacific and Europe. Asia Pacific is expected to register the highest CAGR during the forecast period. For Detailed Functional Safety Market Insights, Visit: Market Segmentation Based on offering, the functional safety market is segmented into component and services. The component segment held the largest share in the functional safety market in 2024. Based on system, the functional safety market is segmented into emergency shutdown system (ESD), turbo machinery control (TMC), fire and gas monitoring, high integrity pressure protection system (HIPPS), burner management system (BMS). The emergency shutdown system (ESD) segment held the largest share in the functional safety Market in 2024. Based on end-user industry, the functional safety market is segmented into oil and gas, chemicals, power generation, pharmaceuticals, food and beverages, automotive, and others. The functional safety market is segmented into five major regions: North America, Europe, APAC, Middle East and Africa, and South and Central America. Stay Updated on The Latest Functional Safety Market Trends: Competitive Strategy and Development Key Players: A few major companies operating in the Functional Safety market include XXXX Trending Topics: Integration of AI, ML, and IoT, Cybersecurity, among others. Global Headlines on Functional Safety " ABLIC acquires development process certification for ISO 26262 Automotive Functional Safety standards from a third-party German certification company " " Murata Obtains ISO 26262 Certification for Functional Safety in Automotive Applications " " Red Hat Reaches Key Milestone in Push to Functional Safety Certification for Red Hat In-Vehicle Operating System " Purchase Premium Copy of Global Functional Safety Market Size and Growth Report (2025-2031) at: Conclusion The functional safety market is poised for significant growth driven by increasing automation, stringent regulations, and the adoption of advanced technologies. Opportunities abound across various industries, regions, and market segments, offering immense potential for companies to innovate, collaborate, and expand their presence. As industries continue to evolve, the demand for robust, integrated, and intelligent safety solutions will only intensify, making functional safety a critical enabler for sustainable and reliable operations in the future. Talk to Us Directly: Trending Related Reports: About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit Mathur E-mail: Phone: +1-646-491-9876 Home - in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
